Insider track record
Board DirectorAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by RICHO ANNA, Director. Director active across 3 companies, notably Adamas Pharmaceuticals Inc. Cumulatively, 13 disclosures have been published. Activity tracked since 2 June 2021. The latest transaction was filed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
3,780 shares0Common StockSEC:0001127602-25-015506:0
933 shares@ US$44.1915.0% of flowCommon stock- deferred stock unitsSEC:0001109357-25-000090:0
1,119 shares@ US$36.8715.6% of flowCommon stock- deferred stock unitsSEC:0001109357-25-000010:0
1,025 shares@ US$40.2314.5% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000168:0
1,161 shares@ US$35.5415.1% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000142:0
2,622 shares0Common StockSEC:0001127602-24-016276:0
1,131 shares@ US$36.4815.0% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000090:0
1,052 shares@ US$39.2114.6% of flowCommon stock- deferred stock unitsSEC:0001109357-24-000014:0
674 shares@ US$40.5810.2% of flowCommon stock- deferred stock unitsSEC:0001109357-23-000081:0
25,000 sharesCommon StockSEC:0001328143-21-000088
25,000 sharesCommon StockSEC:0001328143-21-000088:0
5,000 shares0Common StockSEC:0001328143-21-000061
5,000 shares0Common StockSEC:0001328143-21-000061:0
About RICHO ANNA
Anna Richo is a Board Member at Adamas Pharmaceuticals Inc. She plays a key role in the company's governance, contributing to strategy and overseeing operations. Her experience in the pharmaceutical sector is an asset for Adamas.